Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model

Published:2020-10 Issue: Volume:87 Page:106764
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Kaneko Yoko,Fukahori Hidehiko,Yamagami Kaoru,Kawashima Tomoko,Ito Misato,Akamatsu Masahiko,Marui Takanori,Kato Koji,Takahashi Fumie,Morokata Tatsuaki

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference27 articles.

1. Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy;Zhao;Acta pharmaceutica Sinica. B,2017

2. The role of PI3K in immune cells;Koyasu;Nat. Immunol.,2003

3. Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies;Puri;Front. Immunol.,2012

4. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006;Costenbader;Arthritis Rheum.,2011

5. Targeting phosphoinositide 3-kinase: moving towards therapy;Marone;BBA,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to treat monogenic SLE?;Best Practice & Research Clinical Rheumatology;2024-06

2. Animal models of systemic lupus erythematosus and their applications in drug discovery;Expert Opinion on Drug Discovery;2022-03-14

3. Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus;European Journal of Pharmacology;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3